MENU CLOSE
About Us

Who We Are

Our Social Responsibility

Events

Exhibitions

Activeties

Members

Hospitals

Individuals

Companies

Member Benefits

 
Bio-medical projectsi

State Key Laboratory of Biotherapy

Cooperation

Achievement Exhibition

Scimea Journals

Signal Transduction and Targeted Therapy

News

News Information

 
Home   >  News
09 Jun 2020
399
MedComm | Intermedin promotes vessel fusion by inducing VE‐cadherin accumulation at potential fusion sites and to achieve a dynamic balance between VE‐cadherin‐complex dissociation/reconstitution
Scimea

A closed vascular system is always established by vessel fusion. However, it has been an unsolved mystery that how vessel fusion happened in this process. In this study, Lingmiao Kong et al reported that intermedin (IMD), a calcitonin family member, promotes vessel fusion by inducing endothelial cells (ECs) to enter a “ready‐to‐anchor” state.

 



1598427876(1).png


To create a closed vascular system, angiogenic sprouts must meet and connect in a process called vessel fusion, which is a prerequisite for establishment of proper blood flow in nascent vessels. However, the molecular machinery underlying this process remains largely unknown. Herein, we report that intermedin (IMD), a calcitonin family member, promotes vessel fusion by inducing endothelial cells (ECs) to enter a “ready‐to‐anchor” state. IMD promotes vascular endothelial cadherin (VEC) accumulation at the potential fusion site to facilitate anchoring of approaching vessels to each other. Simultaneously, IMD fine‐tunes VEC activity to achieve a dynamic balance between VEC complex dissociation and reconstitution in order to widen the anastomotic point. IMD induces persistent VEC phosphorylation. Internalized phospho‐VEC preferentially binds to Rab4 and Rab11, which facilitate VEC vesicle recycling back to the cell‐cell contact for reconstruction of the VEC complex. This novel mechanism may explain how neovessels contact and fuse to adjacent vessels to create a closed vascular system.

 

 


 图片(1).jpgFig. 1 IMD promotes vessel fusion in vitro and in vivo.

 

 

 

Article Access: https://onlinelibrary.wiley.com/doi/10.1002/mco2.9

 

 

                                                                                                               

Website for MedComm: https://onlinelibrary.wiley.com/journal/26882663

Looking forward to your contributions.


Breaking News! First Publication of Molecular Biomedicine——Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein
Opening of the 15th West China Hospital International Orthopaedic Forum & the 23rd Orthopaedic Conference of Sichuan Medical Association and the Academic Conference of the Osteopathic Committee of SCIMEA
Member Units Updates | The Thoracic Surgery Academic Forum for Cross-Strait Young and Middle-Aged Scholars was Successfully Held
Max Cynader, Member of The Academy of Science of the Royal Society of Canada Invited to The State Key Laboratory of Biotherapy at West China Hospital of Sichuan University
Dialogue | Masanori Fukushima: First Round of Regenerative Medicine Programs Completed
Latest Events Journals News Members About Us Home
Contact Us

Address: No. 1103-1105, Building 6, S2, Global Center, High-tech Zone, Chengdu

Email: scimea@163.com 

Tel: (0086-)028-63859818   

Fax: (0086-)028-63859818   

Contact: (0086-)19113901604 (wechat:19113901604)


Follow Us
Copyright © 2009-2019 SCIMEA. All rights reserved 蜀ICP备19011649号-1